Cited 0 times in
Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:49:51Z | - |
dc.date.available | 2023-06-02T00:49:51Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194457 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y) | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | A. Luft | - |
dc.contributor.googleauthor | J.A. Alatorre Alexander | - |
dc.contributor.googleauthor | S. Lucien Geater | - |
dc.contributor.googleauthor | K. Laktionov | - |
dc.contributor.googleauthor | K. Sang-We | - |
dc.contributor.googleauthor | G. Ursol | - |
dc.contributor.googleauthor | M. Hussein | - |
dc.contributor.googleauthor | L. Lim Farah | - |
dc.contributor.googleauthor | C.T. Yang | - |
dc.contributor.googleauthor | L.H. Araujo | - |
dc.contributor.googleauthor | H. Saito | - |
dc.contributor.googleauthor | N. Reinmuth | - |
dc.contributor.googleauthor | Z. Lai | - |
dc.contributor.googleauthor | H. Mann | - |
dc.contributor.googleauthor | X. Shi | - |
dc.contributor.googleauthor | S. Peters | - |
dc.contributor.googleauthor | E.B. Garon | - |
dc.contributor.googleauthor | T.S.K. Mok | - |
dc.contributor.googleauthor | M.L. Johnson | - |
dc.identifier.doi | 10.1016/j.annonc.2022.10.365 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422045562 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 9 | - |
dc.citation.startPage | S1569 | - |
dc.citation.endPage | S1570 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1569-S1570, 2022-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.